experienced less than four stressful life events, the Met/Met carriers had higher startle scores ( Figure 1a) . However, no effects of G Â E interaction on startle score were observed among those who experienced higher (four or more) stressful life events (P40.05). These data indicate that less exposure to stressful life events is associated with a higher risk of hyper-arousal in Met/Met, and lower risk of hyper-arousal in Val carriers. As exaggerated acoustic startle is a prominent symptom of PTSD, we also examined the effect of stress on startle expression in the rat model. Relevant to the human data, our animal study demonstrated that inescapable tail shock increased startle response (Figure 1b) , indicating an elevated activation of the autonomic nervous system.
Among those who reported fewer stressful life events, Met/Met had significantly higher PCL total scores than Val carriers ( Figure 1c) . Therefore, at a lower stressful event exposure, Met/ Met had a higher PTSD symptom severity, while Val carriers had lower PTSD symptom severity, indicating that protective effects are overwhelmed at higher levels of stress exposure. A similar phenomenon was observed in a catechol-O-methyltransferase gene association study, showing that those homozygous for the Met allele demonstrated a high risk for PTSD, independent of the severity of traumatic load. 8 Alternatively, neuronal mechanisms may be different in minimally exposed and highly exposed individuals who develop PTSD, supporting different underlying trajectories of PTSD and perhaps different treatments.
Our blood findings demonstrated that Met carriers with probable-PTSD had higher plasma levels of BDNF than the other three groups (Figure 1d ). Our animal data showed that BDNF protein was overexpressed in both the plasma (Figure 1e ) and hippocampus ( Figure 1f ) of acutely stressed rats compared with non-stressed controls, in agreement with others demonstrating that stress results in BDNF overexpression in the hippocampus. 9 These results suggest a BDNF-related compensatory mechanism, 10 and that blood levels mirror levels of BDNF in the traumatic stressinduced hippocampus. BDNF overexpression may be a critical stress response underlying PTSD and the Val66Met BDNF allele may have a significant impact on vulnerability of PTSD. We also noticed that both high and low blood levels of BDNF in PTSD patients were reported (see references 3 and 4 in Supplement). The contrary data, including ours and others', may be explained by differences of methods employed in those studies. For example, samples were collected at different time points, such as during acute or chronic stress stages, and from different populations (see references 3 and 4 in Supplement). Thus, changes in blood BDNF levels in PTSD need to be further confirmed in systematic designed experiments. The distinguishing feature of drug addiction is loss of volition to control drug-taking behaviors. At the neural system levels, however, the precise mechanisms underlying the failure are far from clear. Recent advances in neuroeconomic studies with taskdriven functional magnetic resonance imaging (fMRI) methods have identified two distinct brain networks that jointly influence decision-making processes.
1,2 One, the ventral valuation network, or the b-network in neuroeconomic terms, mediates for immediate rewards, and involves the orbitofrontal cortex, ventral striatum and ventral medial prefrontal cortex (vmPFC). The other is the executive control network, or d-network, which is related to delayed rewards, and involves the lateral prefrontal and parietal cortices. 2 It is challenging to understand how changes in valuation networks could result in irrational addictive behaviors. 3 Using neuroeconomic approaches, 1, 2 we hypothesized that the underlying duality of the b-d-discounting networks that jointly influence valuation was impaired to a pathogenic state in abstinent heroin dependents (HD). To test this hypothesis, we first employed the intrinsic spontaneous blood oxygenation leveldependent (iBOLD) signal measured by the resting-state fMRI (R-fMRI) to replace the traditional BOLD signal activated by taskdriven paradigms. 4 Second, we applied the temporal binding model 5 with seed-based iBOLD signals to establish the link between the b-and d-networks, and measure their imbalanced interaction with a large-scale network analysis method. Thirty-seven male, right-handed volunteers were recruited (22 HD subjects and 15 nondrug users as cognitive normal (CN) subjects). All underwent R-fMRI data acquisition. The characterization of the study subjects, inclusion and exclusion criteria, imaging data preprocessing and seed-based postprocessing procedures have been previously published 6 and are briefly presented in supplemental information section (Supplementary Table S1 ). We selected the nucleus accumbens (NAc) region as a connective node or a 'seed' region to link between the b-and d-networks because the NAc has an important role in drug addiction. 7 Figure 1a (top row) illustrates the manner in which the iBOLD signals between regions of the anterior insula/frontal operculum (aI/fO), and NAc were desynchronized in HD subjects than in CN subjects. 4 As the synchronization of brain signals between neural systems is crucial in facilitating neural communications, as suggested by the temporal binding model, the decreased synchrony between aI/fO and NAc pair indicates that the heroin use may destabilize the neural control systems. 8 The improper function between aI/fO and NAc regions in HD subjects is only one aspect of loss of volition. We examined the functional synchrony between the regional iBOLD signals in the left caudate (lCau) and NAc. As illustrated in Figure 1a (bottom row), the synchronization of lCau-NAc pair in the HD group is significantly higher than in the CN group. The strong link between the ventral (that is, NAc) and the dorsal (that is, lCau) region of striatum through so-called 'spiraling' connections 9 in the HD group indicated the strong trait of motivational drive, as demonstrated previously in animal study. 10 It is plausible that the failure of the top-down executive control and enduring motivational drive involved very complex systems beyond the brain regions that were tested above. With the analysis of covariance, Figure 1b shows the group differences in voxelwise functional connectivity patterns. Specifically, in the b-network, the functional connectivity strength link between the NAc and the bilateral caudate, and amygdala, thalamus and vmPFC are significantly increased in the HD group compared to the CN group. In contrast, in the d-network, the connectivity strength link between the NAc and the dorsal lateral prefrontal cortex, and the aI/fO and other frontal-parietal regions are significantly decreased in the HD group in comparison with the CN group (please see Supplementary Materials Table S2 ).
Next, we converted the voxelwise functional connectivity patterns in Figure 1b Figure 1c shows that the N d index is lower, whereas the N b index is higher in the HD group than in the CN group. These results suggest that through the links to NAc, the b-and d-networks were engaged in the imbalanced interaction in the HD group.
We further examined whether the network activity between b-and d-networks is inversely proportional for individual subjects. Figure 1d shows that the indices of N b and N d have a significant inverse relationship (F (1,13) ¼ 9.10, Po0.0099 for the CN group; F (1,20) ¼ 10.02, Po0.0049 for HD group), indicating the stronger the b-network activity, the weaker the d-network activity, suggesting a 'gating' mechanism involving a strong motivational state that could open the gate of the executive control circuits. 11 The left shift of the curve for HD individuals may indicate that these individuals have a weaker executive control capacity than the CN subjects under the same motivational drive.
The imbalanced functional link between the b-d-networks may shed light on the mechanistic understanding of drug addiction at a large-scale system level. The strong b-network activity of immediate reward overdrives the d-networks activity of inhibitory control. Such a pathogenic state could be very susceptible to interaction with various environmental valences of drug conditioning and tilt the valuation-based decision-making process toward the immediate reward, resulting in the impulsive drugtaking and -seeking behaviors. To help identify effective interventions to limit the cardiovascular side effects of antipsychotics, a three-part hypothesis is described: (1) risk factors for heart disease correlated with antipsychotic drug treatment require an intervention that targets the antipsychoticrelated mechanism of risk; (2) antipsychotic drugs cause weight gain and dyslipidemia at least in part via upregulation of the SREBP transcription factor in the liver and the genes under its control; and (3) Chinese herbal remedies that downregulate SREBP can limit weight gain and dyslipidemia caused by antipsychotics and prevent progression of coronary artery disease.
Antipsychotic drugs increase risk for type 2 diabetes and heart disease. Heart disease is the reason why most individuals with schizophrenia live short lives. Life expectancy is reduced by an average of 15 years and 50-75% of individuals with schizophrenia die from coronary heart disease. Drug-switching trials have confirmed a causal relationship between commonly prescribed antipsychotic drugs (olanzapine, quetiapine or risperidone) and weight gain and dyslipidemia. Both are important risk factors for type 2 diabetes and heart disease. Cognitive-behavioural and psycho-educational interventions to control weight gain in those treated with antipsychotics have shown a modest short-term effect equivalent to a mean 3% change in body weight-not enough to significantly improve cardiovascular health-and not sustained at 1-year follow-up. 1 Cardiovascular risk factors that are changed by exposure to antipsychotics may therefore require interventions that target treatment-related mechanisms of risk if we are to change key physical health outcomes of treated psychosis.
One important mechanism of risk may be the effect of antipsychotic drugs on gene expression. In cell lines derived from human brain tissue, antipsychotic drugs preferentially upregulate genes that control the biosynthesis of cholesterol and fatty acids. 2 This is due to increased proteolytic cleavage of the sterol regulatory element binding protein (SREBP1 and SREBP2) transcription factor. In the brain, these expression changes may have an important role in cell membrane permeability and cell signalling; in peripheral tissue they may have an important role in cardiovascular health. In human liver cells, antipsychotic drugs upregulate key cholesterol transport genes predominantly under the control of liver X receptors, which are in a regulatory feedback loop with SREBP. 3 Upregulation of SREBP in the liver could lead to weight gain and dyslipidemia. There is evidence a similar effect is observed beyond the strict confines of experimental studies. Expression of lipid biosynthesis genes under the control of SREBP1 were significantly upregulated in the peripheral blood of patients treated with olanzapine monotherapy compared with un-medicated matched patient controls. 4 Traditional Chinese herbal remedies, especially in combination, have been proposed for the prevention and treatment of coronary artery disease 5 and several have been shown to downregulate SREBP. 6 These include berberine, danshen, morroniside, fufang zhenzhu tiaozhi fang and fenugreek. 6 Berberine, a plant alkaloid with a long history of medicinal use in both Ayurvedic and Chinese medicine, may be of particular interest. It is found in the roots, rhizomes, stems and bark of plants including Berberis vulgaris (Barberry), Coptis chinensis (Chinese Goldthread) and Hydrastis canadensis (Goldenseal). Alone or as part of a multi-component herbal remedy, Berberine has been used to treat many ailments, including heart disease. 7 Berberine is also a potent hypoglycaemic agent, as good as metformin for the regulation of glucose metabolism in those with newly diagnosed type 2 diabetes and better than Metformin for lowering total cholesterol and triglyceride levels. 8 This is relevant because metformin has been proposed as a treatment for the metabolic side effects of antipsychotics. 9 Three months of treatment with berberine, however, was more effective than metformin for reducing waist circumference, waist-to-hip ratio, total and low-density lipoprotein cholesterol and triglyceride level, and for increasing high-density lipoprotein cholesterol, in women with polycystic ovary syndrome. 10 The INTERHEART study has shown that lipid ratios are the strongest risk factor for first heart attack and that abdominal obesity is a more important risk factor than body weight or body mass index. The greater improvement in waist circumference and lipids after treatment with berberine than metformin may therefore be clinically relevant for those with treated psychosis. Moreover, berberine in combination with policosanol, red yeast extract containing monacolin, folic acid and astaxanthin was more effective than berberine alone in correcting dyslipidemia (Cicero et al. (2007) in the study by Zeng et al.
5
). Traditional Chinese medicine emphasises the value of combining herbal remedies to
